iShares Evolved U.S. Innovative Healthcare ETF

IEIH is an actively-managed fund that offers total market exposure to the US pharmaceutical and biotechnology segment, as defined by the iETF Evolved Sector classification scheme.

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare ETF

Vanguard Health Care ETF

Health Care Select Sector SPDR Fund

Johnson & Johnson continued its long streak of earnings beat. It outpaced revenue estimates as well but cut its full-year guidance on a strong dollar.

JNJ Beats on Q2 Earnings, Cuts View: ETFs in Focus

Virtus LifeSci Biotech Clinical Trials ETF

Loncar Cancer Immunotherapy ETF

ETFMG Treatments Testing & Advancements ETF

Global X Genomics & Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

Invesco Dynamic Biotechnology & Genome ETF

Invesco Dynamic Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF

Pharma and biotech ETFs are in great shape and are trading at a one-month high level.

Pharma & Biotech ETFs at One-Month High: Here's Why

iShares MSCI Argentina & Global Exposure ETF

iShares Interest Rate Hedged Emerging Markets Bond ETF

iShares MSCI Japan Equal Weighted ETF

iShs Crr Hg JPX Shs

iShares MSCI Colombia ETF

iShares Evolved U.S. Consumer Staples ETF

iShares Evolved U.S. Financials ETF

iShares Evolved U.S. Healthcare Staples ETF

iShares Evolved U.S. Media and Entertainment ETF

The issuer typically closes a handful of funds during the month every year.

iShares To Close 11 ETFs In August

iShares Trust - iShares Edge MSCI Multifactor USA Mid-Cap ETF

NEW YORK--(BUSINESS WIRE)--iShares today announced its plans to close the following U.S. -listed ETFs on August 25, 2022. Ticker Fund Name AGT iShares MSCI Argentina and Global Exposure ETF EMBH iShares Interest Rate Hedged Emerging Markets Bond ETF EWJE iShares MSCI Japan Equal Weighted ETF HJPX iShares Currency Hedged JPX-Nikkei 400 ETF ICOL iShares MSCI Colombia ETF IECS iShares Evolved U.S. Consumer Staples ETF IEFN iShares Evolved U.S. Financials ETF IEHS iShares Evolved U.S. Healthcare St

BlackRock Announces Product Updates to 11 U.S.-listed ETFs

iShares MSCI Global Gold Miners ETF

Invesco S&P 500 Low Volatility ETF

Vanguard Consumer Staples ETF

Vanguard International Dividend Appreciation ETF

The pandemic-driven supply chain woes and the resultant red-hot inflation, the Russia-Ukraine war and the resultant hit to the commodity market as well as the central banks' policy tightening in the developed world may cause global growth slowdown in the coming days.

5 ETFs to Counter Imminent War-Induced Global Growth Slowdown

First Trust Morningstar Dividend Leaders Index Fund

Invesco S&P 500 Equal Weight Consumer Staples ETF

Vanguard Value ETF

Real Estate Select Sector SPDR Fund

Uncertainties are playing a big role in the Wall Street due to record-high inflation, Fed policy tightening and Omicron strain of coronavirus. Still, some ETFs may warm up your winter portfolio.

Warm Up Your Portfolio With These ETFs This Winter

VanEck Vectors Biotech ETF

ProShares Ultra Nasdaq Biotechnology

iShares Nasdaq Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

The pandemic has triggered a race to introduce vaccines and treatment options, opening up investment opportunities in the biotech sector.

Take a Look at the Top-Performing Biotech ETFs YTD

BioNTech SE

Cerevel Therapeutics Holdings Inc

CM Life Sciences II Inc - Unit

Pfizer

Reflecting what it considers the vast potential of life sciences companies, Bain Capital is making another huge bet on the industry. The Boston-based investment firm has raised $1.9 billion in a new fund directed at pharmaceutical, biotechnology and medical device companies, reported Endpoints News.

Should Investors Follow Private Equity into Life Sciences?

First Trust Health Care AlphaDEX Fund

VanEck Vectors Pharmaceutical ETF

Upbeat earnings, COVID-19-related sales, compelling valuation and lucrative dividend prospects are boosting pharma and healthcare ETFs.

Pharma & Healthcare ETFs at a One-Year High: Here's Why

The broader medical sector should gain on decent earnings expectations and higher COVID-19-related sales

Time for Pharma and Healthcare ETFs?

NETLease Corporate Real Estate ETF

Nuveen Short-Term REIT ETF

iShares Residential Real Estate ETF

SPDR Dow Jones REIT ETF

The U.S. economic backdrop and investors' sentiments have remained mixed in recent weeks.

2 Sector ETFs Hovering Around All-Time Highs

Fidelity MSCI Health Care ETF

Some biotech and pharmaceutical ETFs are gaining on Tuesday despite news that Johnson and Johnson's coronavirus vaccine has been halted in over two dozen states, after the Food and Drug Administration recommended temporarily suspending its use following reports that some women developed a rare blood clotting disorder. With over 6.8 million doses of the pharmaceutical company's [.

Biotech ETFs Make Gains Tuesday, Despite the J&J Vaccine Pause

Nasdaq Pharm Shs Nasdaq Pharmaceuticals

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development as the outbreak worsens.

ETFs to Shine on Pfizer's Impressive COVID-19 Vaccine Update

WisdomTree U.S. High Dividend Fund

iShares Core High Dividend ETF

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development.

ETFs to Shine as Pfizer's COVID-19 Vaccine Gets a Nod in Europe

Vanguard Extended Duration Treasury ETF

iShares Convertible Bond ETF

iShares Core MSCI EAFE ETF

SPDR Bloomberg High Yield Bond ETF

iShares iBoxx $ Investment Grade Corporate Bond ETF

SPDR MSCI USA StrategicFactors ETF

SPDR S&P 500 ETF Trust

SPDR Nuveen Bloomberg Municipal Bond ETF

iShares Edge MSCI Min Vol USA ETF

Vanguard Short-Term Corporate Bond ETF

Vanguard Dividend Appreciation ETF

Vanguard Total Stock Market ETF

Capital gains are rare in the ETF space, but there are always some.

ETF Tax Benefits Continued In 2020

Biogen

First Trust Nasdaq Retail ETF

First Trust Consumer Staples AlphaDEX Fund

Kroger

Warren Buffett took positions in Biogen and Kroger. Investors who want to follow Buffett's picking of these two value stocks can also play these ETFs as well.

Wanna Be a Value Investor? Follow Buffett & Play 2 ETF Areas

Johnson & Johnson continued its long streak of earnings beat and outpaced revenue estimates. It also raised its guidance for the full year.

JNJ Beats, Ups View: Healthcare ETFs to Buy

Amgen agreed to buy psoriasis and psoriatic arthritis drug Otezla from Celgene for $13.4 billion in cash.

Amgen to Buy Celgene's Otezla: 5 ETF Drugs

Johnson & Johnson beat the second-quarter earnings and revenue estimates but warned on competition from generics and biosimilars that could impact its third-quarter results.

Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat

News for iShares Evolved U.S. Innovative Healthcare ETF ETF (IEIH)